Meta description: The Cooper Companies, Inc. stock shows a slight drop, reflecting ongoing market conditions. Investors monitor key financial metrics and sector stability.
Company Overview
The Cooper Companies, Inc., listed on the NASDAQ Global Select Market under ticker symbol COO, is a specialty healthcare company. Founded in 1958 and headquartered in San Ramon, California, it operates through two main divisions: CooperVision and CooperSurgical. CooperVision develops, manufactures, and markets a wide range of contact lenses, addressing conditions such as myopia, hyperopia, astigmatism, presbyopia, ocular dryness, and eye fatigue. CooperSurgical focuses on family and women’s healthcare solutions, offering products in surgical devices, fertility services, genomics, diagnostics, and contraception.
The company has approximately 16,000 full-time employees and serves a global customer base spanning the Americas, Europe, the Middle East, Africa, and Asia Pacific.
Stock Performance
As of the latest trading session, COO closed at USD 70.11, marking a decrease of 0.35 points or -0.49674% from the previous day. This price is situated within the 52-week range of USD 61.78 to USD 109.37, showing that while the company has experienced higher valuations in the past year, it currently trades closer to its lower bound.
Trading volume stood at 1,439,657 shares, below its average volume of 2,675,656 shares. This reduced activity could signal less short-term investor engagement or cautious trading sentiment. The company’s market capitalization is USD 13.99 billion, positioning it firmly in the mid-to-large-cap category.
The last dividend recorded was 0, meaning the company does not currently distribute cash dividends. This policy indicates a possible focus on reinvesting profits into growth, operations, or acquisitions rather than direct shareholder payouts.
Market Position and Sector
Operating in the Medical – Instruments & Supplies industry, The Cooper Companies benefits from exposure to the broader healthcare sector, which historically demonstrates defensive characteristics in varying economic climates. The firm’s combination of consumer health products through CooperVision and medical devices via CooperSurgical provides diversification within healthcare.
The medical instruments segment often has strong demand drivers including aging populations, increased healthcare access in emerging markets, and ongoing innovation in medical technology.
Governance and Leadership
Albert G. White III is the current Chief Executive Officer. Under his leadership, the company maintains an emphasis on global reach, product quality, and strategic innovation. Continuous investment in research and development supports CooperVision’s competitive position, while CooperSurgical adapts to evolving market needs in reproductive health and surgical products.
Key Financial Data
- Symbol: COO
- Current Price: USD 70.11
- Market Capitalization: USD 13,987,081,855
- Dividend: None (Last dividend: 0)
- 52-Week Range: USD 61.78 – USD 109.37
- Daily Change: -0.35 (-0.49674%)
- Volume: 1,439,657
- Average Volume: 2,675,656
- Exchange: NASDAQ Global Select
- ISIN: US2166485019
- CUSIP: 216648402
- IPO Date: January 21, 1983
FAQ
- Does The Cooper Companies pay dividends?
Currently, the company does not pay dividends, focusing on reinvestment into its operations and growth strategies. - On which exchange is COO listed?
COO is traded on the NASDAQ Global Select Market. - How many employees does the company have?
The Cooper Companies has approximately 16,000 full-time employees. - What is the company’s sector?
It operates in the healthcare sector, specifically Medical – Instruments & Supplies industry.
Conclusion
The Cooper Companies’ latest stock movement shows a mild decline, yet the firm holds a solid market position with a diversified healthcare portfolio. Investors reviewing COO may note its absence of dividends, preference for operational growth, and its established presence in both consumer and professional healthcare products.
The combination of strong industry fundamentals and global reach could provide resilience in the face of market volatility.
Disclaimer
This article is for informational purposes only and does not constitute financial advice. Investors should conduct their own research or consult with a qualified financial advisor before making investment decisions.
Announcement
For full information about the company, see the link below.